Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey

被引:56
|
作者
Kehey, Amy S. [1 ]
Reid, M. Carrington [2 ]
Miller, David H. [3 ]
Fins, Joseph J. [4 ]
Lachs, Mark S. [2 ]
机构
[1] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA
[2] Cornell Univ, Weill Med Coll, Div Geriatr & Gerontol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Div Med Eth, New York, NY 10021 USA
关键词
QUALITY-OF-LIFE; CONGESTIVE-HEART-FAILURE; RECIPIENTS; COMPLICATIONS; DECISIONS; PACEMAKER; VIGNETTES; MANAGEMENT; FREQUENCY; DISEASE;
D O I
10.1016/j.ahj.2008.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Among older adults, implantable cardioverter-defibrillator (ICD) use is increasing. ICD shocks can occur at end of life (EOL) and cause substantial distress, warranting consideration of ICD deactivation discussions. This nationwide physician survey sought to (1) determine if physicians discuss ICD deactivation at the EOL, (2) identify predictors of those discussions, and (3) ascertain physicians' knowledge/attitudes about ICD use. Methods We surveyed 4,876 physicians stratified by specialty (cardiologists, electrophysiologists, general internists, and geriatricians). The mailed survey presented 5 vignettes leg, end-stage chronic obstructive pulmonary disease, advanced dementia) wherein ICD deactivation might be considered and 17 Likert-scaled items. Results Five hundred fifty-eight (12%) physicians returned surveys. Respondents were largely men (77%) and white (69%). Most physicians (56%-83%) said they would initiate deactivation discussions in all 5 vignettes, whereas significantly more (82%-94%) would discuss advance directives and do not resuscitate status. In logistic regression analyses, a history of prior deactivation discussions was an independent predictor of willingness to discuss deactivation (adjusted OR range, 2.8-8.8) in 4 of the 5 vignettes. General internists and geriatricians were less likely than electrophysiologists. to agree that ICD shocks are painful and to distinguish between the ICD's pacing and defibrillator functions. Finally, most physicians believed that informed consent for ICD implantation should include information about deactivation (77%) and endorsed the need for expert guidance in this area (58%). Conclusions Most physicians would discuss ICD deactivation at EOL. The strongest predictor of this was a history of prior discussions. Knowledge about ICDs varies by specialty, and most expressed a desire for more expert guidance about ICD management at EOL. (Am Heart J 2009; 157:702-8.)
引用
收藏
页码:702 / 708
页数:7
相关论文
共 50 条
  • [21] Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator
    Curtis, Jeptha P.
    Luebbert, Jeffrey J.
    Wang, Yongfei
    Rathore, Saif S.
    Chen, Jersey
    Heidenreich, Paul A.
    Hammill, Stephen C.
    Lampert, Rachel I.
    Krumholz, Harlan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (16): : 1661 - 1670
  • [22] Pocket infection as a complication of a subcutaneous implantable cardioverter-defibrillator
    Calvagna, Giuseppe Mario
    Ceresa, Fabrizio
    Patane, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 616 - 618
  • [23] Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias
    Raja, Joel
    Guice, Kenneth
    Oberoi, Mansi
    Whitwell, Samantha
    Asbeutah, Abdul Aziz
    Russell, Alex
    Khouzam, Rami N.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
  • [24] Quality of life in patients with an implantable cardioverter-defibrillator - the significance of clinical factors
    Kochanska, Anna
    Zarzycka, Beata
    Swiatecka, Grayna
    Majkowicz, Mikolaj
    Kozlowski, Dariusz
    Raczak, Grzegorz
    ARCHIVES OF MEDICAL SCIENCE, 2008, 4 (04) : 409 - 416
  • [25] Predictors of Quality of Life, Anxiety and Acceptance in Patients with Implantable Cardioverter-Defibrillator
    Silva, Laisa Arruda
    Silva, Katia Regina
    Saucedo, Sarah Caroline Martins
    Costa, Roberto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (04)
  • [26] Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator
    Habibovic, Mirela
    van den Broek, Krista C.
    Theuns, Dominic A. M. J.
    Jordaens, Luc
    Alings, Marco
    van der Voort, Pepijn H.
    Pedersen, Susanne S.
    EUROPACE, 2011, 13 (12): : 1723 - 1730
  • [27] Deactivation of Implantable Cardioverter Defibrillators in Terminal Illness and End of Life Care
    Kirkpatrick, James N.
    Gottlieb, Maia
    Sehgal, Priya
    Patel, Rutuke
    Verdino, Ralph J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (01): : 91 - 94
  • [28] Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study
    Lee, Kyoung Suk
    Oh, Oonjee
    Miller, Jennifer
    Hammash, Muna
    Thompson, David R.
    Ski, Chantal F.
    Cameron, Jan
    Hwang, Seon Young
    Moser, Debra K.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (07) : 687 - 693
  • [29] Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator
    Costa, Roberto
    da Silva, Katia Regina
    Mendonca, Rodrigo Castro
    Nishioka, Silvana
    Siqueira, Sergio
    Tamaki, Wagner Tetsuji
    Crevelari, Elizabeth Sartori
    Pinho Moreira, Luiz Felipe
    Martinelli Filho, Martino
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2007, 88 (03) : 258 - 264
  • [30] Reel syndrome in a patient with an implantable cardioverter-defibrillator
    Cruz Cardentey, Marleny
    Castro Hevia, C. Jesus A.
    Castaneda Chirino, Osmin
    Falcon Rodriguez, Roywi
    Lopez Martinez, Frank
    CORSALUD, 2018, 10 (03): : 252 - 255